You have landed on a page of the archived Cochrane Community website. This site is not being maintained or updated.

If you are looking for Cochrane Review evidence, please visit Cochrane’s evidence page.

If you are a Cochrane contributor looking for Community resources, please visit the new Cochrane Community website.

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

Warning: Parameter 2 to onepixelout_swftools_flashvars() expected to be a reference, value given in module_invoke() (line 476 of /var/www/archive/includes/

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

In November 2012, a new Cochrane Review brought together evidence from more than 50 randomised trials of selective serotonin reuptake inhibitors to help people recover from a stroke. Gillian Mead, from the Centre for Clinical Brain Sciences at the University of Edinburgh in Scotland tells us how the review began, what it found and what will happen next.

Play Now!

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Download [mp3]  | Read Review
Updated on: January 7, 2013, 11:31

Comments for improvement or correction are welcome.